×
McKesson Inventory 2010-2024 | MCK
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
McKesson inventory for the quarter ending September 30, 2024 was
$24.176B
, a
10.17% increase
year-over-year.
McKesson inventory for 2024 was
$21.139B
, a
7.35% increase
from 2023.
McKesson inventory for 2023 was
$19.691B
, a
5.29% increase
from 2022.
McKesson inventory for 2022 was
$18.702B
, a
2.83% decline
from 2021.
View More
McKesson Inventory 2010-2024 | MCK
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
McKesson inventory for 2024 was
$21.139B
, a
7.35% increase
from 2023.
McKesson inventory for 2023 was
$19.691B
, a
5.29% increase
from 2022.
McKesson inventory for 2022 was
$18.702B
, a
2.83% decline
from 2021.
Related Stocks
Company Name
Market
Cap
Becton Dickinson (BDX)
$64.4B
Cardinal Health (CAH)
$28.6B
West Pharmaceutical Services (WST)
$22B
Labcorp (LH)
$19.8B
Cooper (COO)
$19.7B
Align Technology (ALGN)
$16.6B
Henry Schein (HSIC)
$9.3B
Merit Medical Systems (MMSI)
$6.1B
DENTSPLY SIRONA (XRAY)
$3.8B
CONMED (CNMD)
$2.2B
Patterson (PDCO)
$1.8B
STAAR Surgical (STAA)
$1.3B
Lifevantage (LFVN)
$170M
Pro-Dex (PDEX)
$147M